Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Clinical cancer research : an official journal of the American Association for Cancer Research"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Clinical+cancer+research+%3A+an+official+journal+of+the+American+Association+for+Cancer+Research%22&lookfor=%22Antibodies%2C+Monoclonal%2C+Humanized%22&type=Subject&page=6
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Clinical+cancer+research+%3A+an+official+journal+of+the+American+Association+for+Cancer+Research%22&lookfor=%22Antibodies%2C+Monoclonal%2C+Humanized%22&type=Subject&page=6
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22Clinical+cancer+research+%3A+an+official+journal+of+the+American+Association+for+Cancer+Research%22&lookfor=%22Antibodies%2C+Monoclonal%2C+Humanized%22&type=Subject&page=6
PubPharm (786)
51
A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma
enthalten in:
Clinical cancer research : an official journal of the American Association for Cancer Research
| 2022
von
Wagner, M.
|
Zhang, Y.
|
Cranmer, L.
| +12
Wird geladen...
52
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer : Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials
enthalten in:
Clinical cancer research : an official journal of the American Association for Cancer Research
| 2022
von
Bellmunt, J.
|
de Wit, R.
|
Fradet, Y.
| +28
CommentIn: J Urol. 2023 May;209(5):1025-1026. - PMID 37026649
Wird geladen...
53
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab
enthalten in:
Clinical cancer research : an official journal of the American Association for Cancer Research
| 2022
von
Rosenblat, T.
|
McDevitt, M.
|
Carrasquillo, J.
| +9
Wird geladen...
54
Transcriptomic Determinants of Response to Pembrolizumab Monotherapy across Solid Tumor Types
enthalten in:
Clinical cancer research : an official journal of the American Association for Cancer Research
| 2022
von
Cristescu, R.
|
Nebozhyn, M.
|
Zhang, C.
| +16
CommentIn: Clin Cancer Res. 2022 Apr 14;28(8):1479-1481. - PMID 35121621
Wird geladen...
55
Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study) : A Phase II Study with Biomarker Analysis
enthalten in:
Clinical cancer research : an official journal of the American Association for Cancer Research
| 2022
von
Kao, H.
|
Liao, B.
|
Huang, Y.
| +7
Wird geladen...
56
Model-Based Characterization of the Bidirectional Interaction Between Pharmacokinetics and Tumor Growth Dynamics in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
enthalten in:
Clinical cancer research : an official journal of the American Association for Cancer Research
| 2022
von
Grisic, A.
|
Xiong, W.
|
Tanneau, L.
| +7
Wird geladen...
57
Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma
enthalten in:
Clinical cancer research : an official journal of the American Association for Cancer Research
| 2022
von
Wise-Draper, T.
|
Gulati, S.
|
Palackdharry, S.
| +23
Wird geladen...
58
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma : 3-Year Follow-up and Correlative Biomarker Analysis
enthalten in:
Clinical cancer research : an official journal of the American Association for Cancer Research
| 2022
von
Song, Y.
|
Gao, Q.
|
Zhang, H.
| +19
Wird geladen...
59
Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma : Results from a Multicenter, Phase II Trial
enthalten in:
Clinical cancer research : an official journal of the American Association for Cancer Research
| 2022
von
Cohen, E.
|
Nabell, L.
|
Wong, D.
| +17
Wird geladen...
60
Safety and Efficacy of Pembrolizumab in Combination with Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma : Phase 2 Proof-of-Concept Study
enthalten in:
Clinical cancer research : an official journal of the American Association for Cancer Research
| 2022
von
Taylor, M.
|
Betts, C.
|
Maloney, L.
| +12
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[79]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: Clinical cancer research : an official journal of the American Association for Cancer Research
Medienart
786
Aufsätze
629
E-Artikel
629
E-Ressourcen
157
Gedruckte Aufsätze
Zeitschriftentitel
Clinical cancer research : an official journal ...
Thema
786
Antibodies, Monoclonal, Humanized
752
Journal Article
492
Research Support, Non-U.S. Gov't
429
Antibodies, Monoclonal
270
EC 2.7.10.1
243
Antineoplastic Agents
202
Research Support, N.I.H., Extramural
151
Clinical Trial, Phase I
139
P188ANX8CK
139
Trastuzumab
129
Clinical Trial, Phase II
129
Receptor, ErbB-2
124
Cetuximab
124
PQX0D8J21J
123
2S9ZZM9Q9V
123
Bevacizumab
121
ErbB Receptors
116
Multicenter Study
100
Biomarkers, Tumor
93
DPT0O3T46P
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
145
2020-
371
2010-2019
226
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
786
Englisch
Haven't found what you're looking for?
Wird geladen...